authors
- Chen, CI
- Kouroukis, Tom
- White, D
- Voralia, M
- Stadtmauer, E
- Wright, James
- Powers, J
- Eisenhauer, E
Bortezomib is active in Waldenstrom's Macroglobulinemia (WM) - Results of a National Cancer Institute of Canada (NCIC) phase II study in previously untreated or treated WM.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal